Sabra Healthcare REIT (NASDAQ:SBRA) Sets New 52-Week High – Should You Buy?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $21.28 and last traded at $21.1120, with a volume of 223916 shares trading hands. The stock had previously closed at $21.01.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on SBRA shares. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Friday, May 1st. Wells Fargo & Company increased their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, March 26th. Scotiabank increased their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “sector perform” rating in a research report on Thursday. UBS Group increased their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Wednesday, May 13th. Finally, Truist Financial raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $22.30.

Sabra Healthcare REIT Stock Down 1.7%

The business has a fifty day simple moving average of $20.32 and a two-hundred day simple moving average of $19.62. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The company has a market cap of $5.22 billion, a PE ratio of 32.87, a price-to-earnings-growth ratio of 1.68 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.16. The company had revenue of $221.75 million for the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. The ex-dividend date is Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Hedge funds and other institutional investors have recently bought and sold shares of the company. Rothschild Investment LLC increased its position in Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares during the last quarter. Smartleaf Asset Management LLC increased its position in Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 714 shares during the last quarter. Founders Capital Management acquired a new stake in Sabra Healthcare REIT during the third quarter worth about $28,000. Strengthening Families & Communities LLC purchased a new stake in Sabra Healthcare REIT in the 4th quarter valued at about $29,000. Finally, Danske Bank A S purchased a new stake in Sabra Healthcare REIT in the 3rd quarter valued at about $30,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.